Qube Research & Technologies (QRT)
IOVA icon

Qube Research & Technologies (QRT)’s Iovance Biotherapeutics IOVA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-564,519
Closed -$1.54M – 3811
2025
Q4 		$1.54M Buy
+564,519
New +$1.31M ﹤0.01% 2359
2025
Q2 		– Sell
-972,689
Closed -$3.24M – 3744
2025
Q1 		$3.24M Buy
+972,689
New +$5.02M ﹤0.01% 1749
2024
Q4 		– Sell
-10,362
Closed -$97.3K – 3640
2024
Q3 		$97.3K Sell
10,362
-190,039
-95% -$1.8M ﹤0.01% 2750
2024
Q2 		$1.61M Buy
200,401
+145,391
+264% +$1.56M ﹤0.01% 1727
2024
Q1 		$815K Buy
+55,010
New +$640K ﹤0.01% 2262
2023
Q4 		– Sell
-10,318
Closed -$46.9K – 4525
2023
Q3 		$46.9K Sell
10,318
-118,779
-92% -$775K ﹤0.01% 2890
2023
Q2 		$909K Buy
129,097
+31,066
+32% +$222K ﹤0.01% 1342
2023
Q1 		$599K Sell
98,031
-87,924
-47% -$607K ﹤0.01% 1500
2022
Q4 		$1.19M Buy
+185,955
New +$1.45M 0.01% 1147
2021
Q1 		– Sell
-5,652
Closed -$262K – 2153
2020
Q4 		$262K Sell
5,652
-5,934
-51% -$236K ﹤0.01% 1411
2020
Q3 		$381K Sell
11,586
-47,753
-80% -$1.46M 0.01% 1141
2020
Q2 		$1.63M Buy
+59,339
New +$1.95M 0.02% 715
2020
Q1 		– Sell
-40,522
Closed -$1.12M – 1398
2019
Q4 		$1.12M Buy
+40,522
New +$922K 0.04% 565

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IOVA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Iovance Biotherapeutics (IOVA) in Q1 2026, closing a stake of 564,519 shares — an estimated $1.54M sold.

Qube Research & Technologies (QRT) first reported a position in IOVA in Q4 2019 and held it in 13 quarters. The position peaked at $3.24M in Q1 2025. 286 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Iovance Biotherapeutics position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 564,519 Iovance Biotherapeutics shares in Q1 2026, an estimated $1.54M.
  • Qube Research & Technologies (QRT) first reported a position in Iovance Biotherapeutics in Q4 2019 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Iovance Biotherapeutics position peaked at $3.24M in Q1 2025.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.